Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Jonthan Brown

  • Home
  • Author: Jonthan Brown

Nike’s sentimental slump due to transitions and China store closures

Transitions in South America coupled with store closures in China drove a decline in Nike’s margins and sentiments, says GlobalData, a leading data and analytics company. GlobalData’s Company Filing Analytics platform found that Nike’s overall sentiment score declined by 9.4% in Q4 2019 (ending February 29, 2020) compared to Q3 2019 (ending November 30, 2019). Despite reporting a good quarterly revenue growth, Nike’s sentiments were affected due to the impact on its net […]
Read more

Healthcare sector witnesses decline in deal activity during the week ended April 12

The number of deals announced in the global healthcare sector (including pharmaceuticals and medical equipment) declined by 28% during the week ended April 12, 2020 compared to the previous week, according to GlobalData’s deals database. Aurojyoti Bose, Analyst at GlobalData, comments: “The decline was subsequent to two consecutive weeks of growth in deal activity. Deal activity in the healthcare sector has remained inconsistent due to uncertainty and volatile market conditions since the coronavirus outbreak.” Deal activity declined in the key markets such as the US and China during the week ended April 12. The announcement of venture financing, partnership, licensing agreement and merger and […]
Read more

Life insurance claims set to spike amid coronavirus pandemic

Life insurance is a sector where insurers are set to struggle against the vast number of claims, with France set to be hit the hardest, says GlobalData, a leading data and analytics company. Out of the five* countries to have had the most confirmed cases of COVID-19, France has the highest life insurance penetration rate, […]
Read more

COVID-19 pandemic affects development of Alzheimer’s drugs

With many countries putting clinical trials studies on hold, pharmaceutical companies are shifting their overall priorities away from some current indications toward COVID-19. This could put several Alzheimer’s Disease (AD) drugs, of which there are 38 in Phase I, 19 in Phase III and 37 in Phase II, at risk of delay, says GlobalData, a leading data and […]
Read more

Falling ad revenue to hurt TV broadcasting

COVID-19 has been having a devastating impact on the TV broadcasting industry as firms have been reluctant to spend on ads, says GlobalData, a leading data and analytics company. Danyaal Rashid, Thematic Analyst at GlobalData, comments: “COVID-19 has led to significant cuts in TV ad spending, affecting those broadcasters that rely on ad revenue to […]
Read more

Biomarkers heavily used as diagnostic tools in COVID-19 trials

Biomarkers are a beneficial tool in the search for a COVID-19 vaccine and will help speed up clinical trials, reduce costs of development, guide subject selection, reduce patient safety risks and allow for easier verification of the mechanism of action, says GlobalData, a leading data and analytics company. According to GlobalData’s Biomarkers database, the top […]
Read more

Novo Nordisk’s dominance in GLP-1RA market to continue with arrival of Rybelsus and strong sales for Ozempic in 2019

Novo Nordisk will continue to dominate a large share of the glucagon-like peptide-1 receptor agonist (GLP-1RA) market with the arrival of Rybelsus and Ozempic’s strong global sales of $1.65bn in 2019. This will enable the company to maintain its well-established position in the wider diabetes market, according to GlobalData, a leading data and analytics company. Akash Patel MSc, Pharma Analyst at GlobalData, comments: “Ozempic (semaglutide) is an injectable GLP-1RA indicated for the treatment of type 2 diabetes (T2D). Since its US launch in February 2018, the drug’s market share has grown due to its impressive glycemic and non-glycemic benefits. The drug also […]
Read more

Hong Kong recovery strategy could prove to be a success

Following today’s news that Hong Kong tourism chief, Dane Cheng, has stated that tourism will be returning back to normality in July and the destination will be focusing on attracting mainland visitors and new markets; Amber Barnes, Travel and Tourism Analyst at GlobalData, a leading data and analytics company, offers her view on the recent announcement: “China is a dominant source market for Hong Kong, accounting for 77% of arrivals in 2019. Focusing marketing efforts on this source market will also boost tourism numbers and allow Hong Kong decrease its recovery period. “Hong Kong tourist […]
Read more

Greece is in control of COVID-19 pandemic following successful second joint renewable auction

Following the news that Greece held its second joint renewable auction for solar photovoltaics (PV) and wind power projects amidst the COVID-19 pandemic, awarding 502.9 megawatt (MW) of renewable capacity to five participants; Somik Das, Power Analyst at GlobalData, a leading data and analytics company, offers his view: “The strong participation and the success of the auctions itself suggest that Greece’s renewable sector is facing the brunt of the pandemic well. Big players such as EMV, Heliotherma Energy and Greece based Panagakos Group […]
Read more

Deliveroo and Morrisons’ partnership epitomises COVID’s acceleration of shopper habits

Following the news that Morrisons is partnering with Deliveroo to launch a new rapid delivery scheme from 130 of its stores: Thomas Brereton, Retail Analyst at GlobalData, a leading data and analytics company, offers his view on the situation: “Over the past few weeks, one of the major issues faced by supermarkets has been a surge in demand for home delivery options for food and groceries, as shoppers seek […]
Read more

Rheumatology patients treatment jeopardized by coronavirus pandemic

With the global COVID-19 pandemic, many patient groups are at an increased risk of infection and this extends to rheumatology patients prescribed immunosuppressant medication. The outbreak has presented these patients with medical and logistical difficulties that will certainly jeopardize their treatment, says GlobalData, a leading data and analytics company.  Antoine Grey, MBiochem, Senior Healthcare Analyst […]
Read more

AstraZeneca gains approval for Koselugo in rare neurological disorder after 17 years of development

Following the news that AstraZeneca’s Koselugo (selumetinib) has been approved by the US Food and Drug Administration (FDA) for the treatment of a rare neurological disorder; Philippa Salter, Neurology & Ophthalmology Analyst at GlobalData, a leading data and analytics company, offers her view: “Previous treatments for neurofibromatosis type 1 (NF1) in pediatric patients, who have […]
Read more

UK supermarkets must follow French example of COVID-19 policy synchronisation

Following the news that French supermarkets Carrefour and Auchan are working together to create standardized practices:  Thomas Brereton, Retail Analyst at GlobalData, a leading data and analytics company, offers his view on the situation:  “We have seen many UK supermarkets adapt quickly and act sympathetically during this crisis, but, as the situation continues to evolve, […]
Read more

COVID-19 crisis will make drones an everyday technology

The use of drones in response to COVID-19 will make technology part and parcel of today’s society, says GlobalData, a leading data and analytics company. Drones are already being used around the world as a law enforcement tool to order public back to their homes and disinfect public places. They are also starting to be […]
Read more

US consumers losing jobs and health insurance due to COVID-19

Workers in the US are facing the daunting process of losing both their jobs and consequently health insurance as the two are often tied together, says GlobalData, a leading data and analytics company. The country has become the new epicenter of the coronavirus pandemic, having recorded more cases than any other country. Citizens do not […]
Read more
1 … 34 35 36 37